Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is one of the major pathways for cytokine signal transduction. However, the role of the JAK/STAT pathway in liver ischemia/reperfusion is not clear. This study focuses on Janus kinase-2 (JAK2), which functions upstr
Reply: Blockade of Janus kinase 2 signaling ameliorates mouse liver damage due to ischemia and reperfusion
โ Scribed by Ricky Harminder Bhogal; Simon C. Afford
- Book ID
- 102468646
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 43 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.22159
No coin nor oath required. For personal study only.
โฆ Synopsis
Liver Transplantation 1 does indeed show that Janus kinase 2 (JAK2) inhibitors reduce lipopolysaccharide (LPS)-mediated mouse hepatoma cell apoptosis. They cited previous work showing that primary mouse hepatocytes and mouse hepatoma cells respond to LPS stimulation by expressing functional toll-like receptor 4.
๐ SIMILAR VOLUMES
Neutrophils are considered crucial effector cells in the pathophysiology of organ ischemia/reperfusion injury (IRI). Although neutrophil elastase (NE) accounts for a substantial portion of the neutrophil activity, the function of NE in liver IRI remains unclear. This study focuses on the role of NE